Evaluation of Hexadecyloxypropyl-9-R-[2-(Phosphonomethoxy)Propyl]-Adenine, CMX157, as a Potential Treatment for Human Immunodeficiency Virus Type 1 and Hepatitis B Virus Infections
You are viewing the correction.
VIEW THE CORRECTED ARTICLEVolume 51, no. 10, p. 3505-3509, 2007. Page 3506, column 1, line 25: “HDP-(S)-HPMPA” should read “CMX157” both times in this line.
Information & Contributors
Information
Published In
Antimicrobial Agents and Chemotherapy
Volume 51 • Number 12 • December 2007
Pages: 4538
Copyright
© 2007 American Society for Microbiology.
History
Published online: 1 December 2007
Contributors
Metrics & Citations
Metrics
Note:
- For recently published articles, the TOTAL download count will appear as zero until a new month starts.
- There is a 3- to 4-day delay in article usage, so article usage will not appear immediately after publication.
- Citation counts come from the Crossref Cited by service.
Citations
Citation
2007.
Evaluation of Hexadecyloxypropyl-9-R-[2-(Phosphonomethoxy)Propyl]-Adenine, CMX157, as a Potential Treatment for Human Immunodeficiency Virus Type 1 and Hepatitis B Virus Infections. Antimicrob Agents Chemother
51:.
If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. For an editable text file, please select Medlars format which will download as a .txt file. Simply select your manager software from the list below and click Download.